MRNA vs OOMA · rev $1.94B vs P/E 52, $468.2M cap
Moderna Inc (MRNA) versus Ooma Inc (OOMA) — a side-by-side from cached financials, not a winner call.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stephane Bancel.
Ooma Inc (OOMA) is a software - application company listed on US.
Latest reported MRNA revenue for 2025-12-31 was $1.94B. Net income was -$2.82B. Revenue was down 39.9% from 2024-12-31 to 2025-12-31. MRNA currently screens at market cap $24.52B.
OOMA does not have a complete income-statement cache yet.
MRNA currently screens at market cap $24.52B. OOMA currently screens at market cap $468.2M and trailing P/E 51.6.
Not investment advice. Open the MRNA and OOMA stock pages for the full models.
Not investment advice.